Additionally, both blood‐ and stool‐derived BAFF demonstrate high specificity (over 93%), indicating that BAFF could serve as a promising biomarker for the diagnostic differentiation of IBD.78 This evidence concerns the gene TNFSF13B and inflammatory bowel disease.